Maropitant
Maropitant citrate
Reviewed by the VetSheet Veterinary TeamUpdated Apr 13, 2026Evidence-based veterinary reference
Doses are a clinical reference for licensed veterinary professionals. Always confirm against the current label and the individual patient.
Dosing by species
π NA β North Americaπ EU β Europe
Dogs
| Indication | Dose | Route | Frequency | Duration | Region |
|---|---|---|---|---|---|
| Treatment and prevention of vomiting (except motion sickness); prevention of chemotherapy-induced nausea | 2 mg/kg | PO | q24h | Up to 14 days | π EU |
| Prevention of vomiting induced by motion sickness | 8 mg/kg | PO | q24h | Maximum 2 consecutive days | π EU |
| Treatment and prevention of vomiting; chemotherapy-induced nausea (injectable) | 1 mg/kg (1 ml/10 kg) | SC or IV | q24h | Up to 5 consecutive days | π EU |
- Treatment and prevention of vomiting (except motion sickness); prevention of chemotherapy-induced nausea: Dogs 8 weeks of age or older. Give more than 1 hour in advance to prevent vomiting; effect lasts approx. 24 h. A correct dose cannot be accurately achieved in dogs under 3 kg.
- Prevention of vomiting induced by motion sickness: Dogs 16 weeks of age or older. Give at least 1 hour before the journey; anti-emetic effect persists at least 12 h.
- Treatment and prevention of vomiting; chemotherapy-induced nausea (injectable): IV administration must be given as a single bolus without mixing with other fluids.
Cats
| Indication | Dose | Route | Frequency | Duration | Region |
|---|---|---|---|---|---|
| Treatment and prevention of vomiting (injectable) | 1 mg/kg (1 ml/10 kg) | SC or IV | q24h | Up to 5 consecutive days | π EU |
- Treatment and prevention of vomiting (injectable): IV administration must be given as a single bolus without mixing with other fluids. The injectable is the only Cerenia presentation authorised in cats β the tablets are dogs only.
Doses are a clinical reference for licensed veterinary professionals. Always confirm against the current label and the individual patient.
Overview
A neurokinin-1 (NK1) receptor antagonist that blocks the pharmacological action of substance P in the central nervous system, widely used in veterinary medicine to prevent and treat vomiting.
Safety & warnings
Adverse effects
- Pain at injection site
- Lethargy
- Anorexia
- Diarrhea
- Hypersalivation
VetSheet drug reference is intended for licensed veterinary professionals as a clinical decision-support aid, not a substitute for professional judgement or the manufacturerβs current label.
